Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.

In its alert, the MHRA said: “Healthcare professionals should advise all recipients of Abrysvo and Arexvy that they should be ...

The variant is "very difficult to diagnose," Kiprovski said. There's no one test to determine if a person has Guillain-Barré syndrome or any of its variants, so doctors rely on clinical ...

INTRODUCTION Treatment-related fluctuation (TRF) in patients with Guillain-Barré syndrome (GBS) describes those cases in which clinical deterioration occurs one or more times after initial improvement ...

CIDP is often considered the chronic form of Guillain-Barré Syndrome and, as such, can be more problematic in that it lasts longer, causes more damage and is more difficult to recover from.

The tally of suspected Guillain-Barre syndrome (GBS) cases in the Pune region has reached 180, with the detection of seven cases, while a 64-year-old woman became the first patient diagnosed with the ...

Following the death of a 10-year-old boy from Tiruvallur district who was diagnosed with Guillain-Barre Syndrome (GBS), an autoimmune neurological disorder, health officials have said that there ...

Pastor Brian Dube, lead pastor at Christian Fellowship Center on Church Street in New Bedford, shows a photo of when he was ...

Brian Dube of Acushnet, lead pastor at a New Bedford church, was diagnosed with Guillain-Barré syndrome. The disease is a rare neurological disorder and can be fatal, causing paralysis.

A man suspected to have contracted Guillain-Barre Syndrome (GBS) has died in Maharashtra's Solapur district, while the number of cases of the immunological nerve disorder in Pune has crossed 100.

Amid a spike in Guillain-Barré Syndrome (GBS) cases in Pune district, a 64-year-old female patient died on Thursday while undergoing treatment at Yashwantrao Chavan Memorial Hospital (YCMH) in ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination ...